Clinical Trial Update: Sutent + Taxol for Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sunitinib (Sutent) in combination with paclitaxel (Taxol) for advanced esophageal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Sutent (sunitinib)
• Taxol (paclitaxel)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-16